We’ve already helped several success stories get started. Here’s what our portfolio companies have said about us.
Case studies
MONCYTE Health:
Revolutionizing cardiovascular diagnostics
MONCYTE Health develops innovative diagnostic technology to optimize treatment and prevention of cardiovascular disease, the world’s leading cause of death. The company’s proprietary platform provides unique insights into cellular lipid processing, enabling pharmaceutical companies to better understand disease progression and the cardiovascular effects of their drugs. By targeting cellular mechanisms, MONCYTE Health aims to improve treatment outcomes and reduce cardiovascular risk more effectively.
”MONCYTE Health was looking for an early-stage life science investor that had specific knowledge in diagnostics and the ability to support our company going forward.
For us, it was important to secure capital, but it was equally important to have an investor with a good reputation, strategic vision, and good communication with whom we could work long term. Almaral is a founder-friendly and professional investor providing mentorship, advice, and excellent guidance in all aspects of the business. It has been a pleasure working with them.”
Tamara Alagirova
CEO and Co-founder, MONCYTE Health
Orla and Almaral:
A partnership for impactful growth
We sought a partner aligned with our vision of making primary care more accessible, impactful and convenient. As lead investor, Almaral has provided valuable insights into health systems and international business growth, shaping our strategy and laying the foundation for expansion.
We value strong collabotive partnerships. Almaral’s team-oriented approach and commitment to support our development and growth is genuine and proactive. Almaral’s input has helped us to clarify and align the objectives and metrics to serve our strategy. We at Orla look forward to the shared journey in the years ahead.
Tuomas Mäkynen
CEO, Orla
Fepod:
“It’s been a delight to work
with Almaral.”
”Fepod was looking for an early-stage investor with intensive knowledge in the field of diagnostics. Almaral, with its unique expertise and vast network of professionals, has proven to be the perfect fit for us.
Our primary goal was to secure the initial capital needed to launch our company and products. But the benefits of our collaboration have extended far beyond the initial seed funding. Almaral has stood behind our company and vision in later stages as well, providing crucial support and mentoring.
It’s been a delight to work with Almaral – direct and honest communication with strong vision on achievable business targets. Just the kind of partner every startup entrepreneur should have on their side.”
Jussi Pyysalo
CEO, Fepod
Genomill:
“Accomplished, straightforward, and transparent.”
”Right from the start of our cooperation, Almaral’s straightforward approach made a strong impression. After the initial discussions, everything started happening rapidly, communication was clear, and our collaboration quickly took off.
Almaral possesses a unique hands-on expertise in the field of biotechnology and a proven track record in successful commercialization of products in our market. Through their personal experience, they can provide us with advice and guidance for the successful building of our business.
If I described Almaral in three words, they would be: accomplished, straightforward, and transparent.”
Manu Tamminen
CEO, Genomill
Marginum:
“Almaral provides
a comprehensive solution.”
”Through our collaboration with Almaral, we sought expert insights into how to enter the market with a new health tech innovation and how to strategically carry out commercialization efforts.
The assistance we have received has been very positive and diverse. For instance, during our recruitment process, we received a tip about a candidate who turned out to be a perfect fit, and we subsequently hired that candidate.
It’s noteworthy how Almaral provides a comprehensive solution for health technology and biotechnology startups. The collaboration between us has been smooth and natural from the beginning, showcasing the experience, expertise, and broad networks of Almaral’s team.”
Samu Lehtonen
CEO, Marginum
